Page last updated: 2024-08-22

trolamine salicylate and B16 Melanoma

trolamine salicylate has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bir Kohli, P; Caplazi, P; Cheng, JH; Deshmukh, G; Dugger, DL; Fong, R; Hamilton, G; Johnson, A; Junttila, MR; Kwon, YC; Lee, WP; Liederer, BM; Lupardus, P; Maltzman, A; McKenzie, BS; Newton, K; Patel, S; Ramaswamy, S; Sujatha-Bhaskar, S; van Lookeren Campagne, M; Varfolomeev, E; Vucic, D; Webster, JD; Wickliffe, KE; Zhang, J1

Other Studies

1 other study(ies) available for trolamine salicylate and B16 Melanoma

ArticleYear
RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases.
    Cell death and differentiation, 2020, Volume: 27, Issue:1

    Topics: Animals; Arthritis; Cell Death; Cell Line; Cell Line, Tumor; Colitis; Dermatitis; Female; Gene Knock-In Techniques; Humans; Ileitis; Inflammation; Intracellular Signaling Peptides and Proteins; Male; Melanoma, Experimental; Mice; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Rats; Receptor-Interacting Protein Serine-Threonine Kinases

2020